Next year, a new company will take over the printing, storage and distribution of all the public information leaflets and other national printed resources for the NHS Screening Programmes.
...inequalities affect screening There are many people who decide not to be screened, which is entirely their choice. These people might have screening, but only if we provide better information...
...wanted to: hear examples of positive outcomes for affected children be put in touch with patient organisations who could find someone in the community to support them meet young people...
...to complete screening. The screening laboratory stores them for a minimum of 5 years. Laboratories use residual blood spots to check screening results, for testing equipment or methods, and for...
I’m the Sickle Cell and Thalassaemia Screening Lead at Northampton General Hospital and Kettering General Hospital. For the past year I’ve been on secondment as national project lead for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
...decision will be personal to them. The UK National Screening Committee (UK NSC) is consulting on its guidance covering the development, production and review of information to support all UK...
...of screening new links to promotion of vaccinations in pregnancy and reporting viral rash reinforcing the importance of sexual health awareness and protection in pregnancy follow-up of women who miscarry...
Today we’ve published our latest easy read information leaflet to help ensure screening is accessible to individuals with learning disabilities and low literacy levels.
Back in November 2016 and March 2017 we published blog articles about the additional option of non-invasive prenatal testing (NIPT) to the fetal anomaly screening pathway.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.